Global campaign for equitable access to all Vertex CFTR modulator drugs which can extend & save the lives of people with cystic fibrosis (CF) wherever they live
@chandan6661@Dev_Fadnavis@PMOIndia@rashtrapatibhvn@VertexPharma We’ve been working with Bangladeshi manufacturer, Beximco Pharma, to deliver a more affordable generic version of CF miracle drug Trikafta. Hopefully patients in India will be able to access this too in the months ahead. 🫁🌎💊
https://t.co/zx0D6EsACW
The cost of meds was too high for thousands of #CF patients.
We worked with @VertexSaveUs & @3rdworldnetwork to approach a Bangladeshi company to make a generic version at a fraction of the price - it’s now on the way.
This will change lives.
https://t.co/9A4p3RJqil
🚨 BREAKING: Yesterday at #NACFC we announced the first truly affordable #cysticfibrosis modulator is here.
The CF community is reviving the CF Buyers’ Club with Triko:
- A generic version of Trikafta
- Costs just $6,375 per child/yr
🔗 To find out more: https://t.co/KSypi9EoTk
💥Historic news today!💥
#Trikafta (ETI) is the first CF treatment to be added to the @WHO ‘Essential Medicines List’.
We’ve worked tirelessly with academics & allies to make this possible. This listing must translate into access for all.
Govt’s & @VertexPharma must step up.
So many years of work behind today's decision
#Trikafta is on the @WHO Essential Medicines List!
Well done @VertexSaveUs@JustTreatment & all the advocates/medical professionals worldwide who contributed to this ground breaking achievement
Now @VertexPharma - DROP YOUR PRICES
Huge news today that Trikafta (ETI) is now on the @WHO ‘Essential Medicines List’. The first ever CF drug to be listed💥
So proud to be part of a group of academics/advocates that worked on the submission 🥰
@VertexPharma & govt’s must act now. Trikafta for all! #EML 👊💊🌎🫁
@Le_Lemgruber We completely agree with you Leticia. It was so good to collaborate with you - you were absolutely key to this threat and the success in Brazil ❤️
Great to be mentioned in this paper about access to CF modulators in Brazil, following our involvement there in 2022/3.
We know threatening Vertex’s monopoly with compulsory licensing is the ONLY language they respond to = lower pricing.
Read more: https://t.co/YKBfgfnJJZ 🇧🇷
@VertexSaveUs@VertexPharma@CompComSA This is what keeps me up at night. How can there be miracle drug for those of us born with CF, yet the barrier to get it is $30,000 per month?!?! UNCONSCIONABLE
South African #cysticfibrosis patient JC speaks about about @VertexPharma’s inhumane & inequitable ‘access programme’ that means that only the privileged can access Trikafta, while he & the other 50% are left behind.
The @CompComSA must re-open their investigation now. 😡
Today we’ve been @CompComSA to deliver a dossier of evidence showing that @VertexPharma has misled them & that 50% of CF patients in SA are still dying w/o access to #Trikafta.
They must reopen their investigation into Vertex’s anti-competitive behaviour.
No one left behind!
'Access for the Privileged' SA Health Advocates Demand Competition
Commission Reopen Vertex Investigation
1/2 of eligible cystic fibrosis patients in public & private health sectors still cannot access life-saving drug.
https://t.co/nrYT4vyiUr
@VertexSaveUs@JustTreatment
@VertexSaveUs@VertexPharma Dear Vertex-You are truly vile. How dare u raise prices on a life saving drug that none of us can afford? WHO has an extra $30,000 per month?!?!
Signed-a CF WARRIOR
Nothing surprises us when it comes to the greed & inhumane behaviour of @VertexPharma.
Children are dying w/o access to #Trikafta due to the unaffordable price.
Vertex’s response - to INCREASE the price.
That says everything about their utter disregard for CF patients 🤬
Amazing news from #Turkey today - CF patients aged 6+ will have access to #Trikafta. ❤️
BUT… Why did it take 6 years whilst @VertexPharma blocked efforts to access affordable alternatives? How many young lives were lost? 😞
And 000’s globally are still waiting 😡
#CFCantWait
It’s hard to believe what happened at #ECFC2025...
@VertexPharma SHUT US OUT - three CF mums - from their "community meeting" for wanting to ask critical questions about #Trikafta access.
But we didn't stop there…
Read full blog to find out more ⬇️
https://t.co/L45Mi7ifKK